Pfizer

Traded on the St. Petersburg Stock Exchange
Pfizer is an American multinational pharmaceutical corporation headquartered in New York City. It is one of the world's largest pharmaceutical companies. The company develops and produces medicines and vaccines for a wide range of medical disciplines, including immunology, oncology, cardiology, endocrinology, and neurology. Its products include the blockbuster drug Lipitor, used to lower LDL blood cholesterol. The most famous brands are: "Lyrica", "Diflucan", " Zithromax", "Viagra", "Celebrex".
Pfizer stock price chart
+38%
P/E adj.
Net profit (adj.)
P/B
Book value
Debts
Net debt
Yield
Growth potential

Pfizer balance sheet

Report period2017 2018 2019 2020 2021 Q1 22
End date of the reporting period
Capitalization, $
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

Pfizer cash flows

Report period2017 2018 2019 2020 2021 Q1 22 TTM
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
Adjusted Earnings
EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS
Adjusted EPS

Pfizer multipliers

Report period2017 2018 2019 2020 2021 Q1 22 TTM
P/E
P/E adj.
E/P
E adj./P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
EV/EBITDA

Pfizer profitability

Report period2017 2018 2019 2020 2021 Q1 22 TTM
ROA
ROE
ROS
Gross margin
EBITDA Margin
Operating margin
Pfizer assets
Pfizer cash flows
Pfizer dividends
3.25%

Pfizer shares

TickerNameTypeNominal valueISINPrice
PFE:USPfizer Inc.Common share-US7170811035$53.71
PFE-RM:RMPfizer (MOEX)Common share$0.05US7170811035RUB 2,902

Pfizer expected events

DateTypeNoteSource
10.06.2022 10:00
Dividends
The company will pay dividends of $0.4 per common share for Q2 Fiscal Year 2022.Pictogram of investors.pfizer.com  investors.pfizer.com
10.06.2022 10:00
Dividends
The company will pay dividends of $0.4 per common share for Q2 Fiscal Year 2022.Pictogram of investors.pfizer.com  investors.pfizer.com
Pfizer news
10.05.2022
Pfizer is buying Biohaven Pharmaceutical, which developed the drug NURTEC ODT approved for emergency use in the treatment of migraine in adults. The deal is valued at $11.6 billion and is expected to close in early 2023.
03.05.2022
Pfizer's GAAP net income for 3 months of 2022 was $7.87 billion, up 61.1% from $4.886 billion in the previous year. Revenue increased by 76.8% to $25.661 bln against $14.516 bln a year earlier.
28.04.2022
The Pfizer Board of Directors announced a quarterly dividend of $0.4 per share. The last day to buy securities to receive the dividend is May 11, 2022. The annual dividend yield may reach 3.25%.
27.04.2022
European Union approved the drug VYDURA developed by Pfizer and Biohaven Pharmaceutical. VYDURA is for the treatment of migraine in adults.
General information
Company namePfizer
Tags#pharmacy, #s&p500 index, #coronavirus, #vaccines
SectorHealth Care / Pharmaceuticals, Biotechnology & Life Sciences / Pharmaceuticals / Pharmaceuticals
Business address235 E 42ND ST NEW YORK NY 10017 2125732323
Mailing address235 E 42ND ST NEW YORK NY 10017
Websiteinvestors.pfizer.com
Information disclosurewww.sec.gov